Related Experiment Video
Updated: Jul 3, 2026
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
Assessment of the Performance of an AI-Driven SpeechEnhancer Algorithm for Speech Enhancement Following Laryngeal
Kipras Pribuišis1, Rytis Maskeliūnas2, Nora Ulozaitė-Stanienė1
1Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Objective:
The present study aimed to evaluate the effectiveness of the performance of an AI-driven SpeechEnhancer algorithm speech synthesis following laryngeal oncosurgery.
Methods:
The original and synthesized speech samples from 77 patients after laryngeal oncosurgery were evaluated in this study. A panel of four experts conducted the auditory-perceptual speech evaluation using the IINFVo and the Similarity Mean Opinion Score (SMOS) scales. The acoustic analysis of speech samples was performed using the Average Voicing Evidence (AVE), Proportion of Voiced Frames (PVF), Proportion of Voiced Speech Frames (PVS) and Acoustic Substitution Voicing Index (ASVI) measures.
Results:
The synthesized speech samples outperformed the original speech in acoustic and auditory-perceptual evaluation. The mean total IINFVo scores were statistically significantly higher (P < 0.05) in the synthesized speech samples group [IINFVo = 5.59 (SD = 0.83)] when compared with the original speech samples [IINFVo = 4.18 (SD = 1.11)]. The mean SMOS score of 2.42 (SD = 1.19) demonstrated a modest level of similarity between the synthesized and original speech samples. A statistically significant (P < 0.05) improvement of acoustic AVE, PVF, and PVS parameters in synthesized speech samples was observed. The quality of the synthesized speech [ASVI = 19.22 (SD = 7.44)] statistically significantly (P = 0.001) surpassed the original substitution voicing speech quality (ASVI = 9.39 (SD = 4.34).
Conclusion:
The AI-driven "SpeechEnhancer" algorithm is a promising tool for speech rehabilitation after laryngeal oncosurgery. It demonstrates the potential for use in clinical settings by healthcare professionals and patients following laryngeal carcinoma surgery.
